Navigation Links
FDA Approved Nerve-Stimulation Therapy Now Available In New York

Vagus Nerve Stimulation therapy is a FDA approved long-term treatment regime for patients with treatment resistant depression (TRD). // This form of therapy is now being offered to patients at NewYork-Presbyterian Hospital/Columbia University Medical Center.

The treatment is now the first treatment specifically approved for TRD in patients over 18 years of age in whom antidepressant therapy has been unsuccessful atleast in four or more of the depressive episodes.

The treatment is instituted with the help of a small pacemaker-like device implanted in the chest area. The device sends mild pulses to the brain through the vagus nerve in the neck. A generator that runs under the skin to the left vagus nerve powers the device through a thin insulated wire.

The vagus nerve is one of the 12 cranial nerves and serves as the body’s information highway connecting the brain to many major organs. Several studies have shown that VNS Therapy may modulate neurotransmitters such as serotonin and norepinephrine thought to be involved in mood regulation.

Major depressive disorder is one of the most prevalent and serious illnesses in the U.S., affecting nearly 19 million Americans every year and more than 4 million people do not respond to conventional treatment such as psychotherapy, antidepressant medications, and even electroconvulsive therapy.

Nearly half of patients with an average of 25 years of major depressive disorder and multiple treatment trials realized some clinical benefit; one-third of patients had at least a 50 percent improvement in their depression; and one out of six was depression-free after treatment with VNS Therapy. Patients also reported significant improvements in quality-of-life areas, such as vitality, mental health, emotional well-being, and social functioning.

The new form of treatment is an important development in people with depression who need safe and effective therapeutic options. Several studie
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New FDA Approved Drug NATRECOR For Heart Failure Patients
4. New Oral Rinse For Gingivitis Approved By FDA
5. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
6. AIDS Generic Drugs Approved by FDA for Sale in US
7. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
8. Pfizer’s Eraxis Approved By The FD
9. Inhalers for Kids Was Approved By the FDA
10. Alcoholism Drug Vivitrol Approved By FDA
11. Drug Approved to Curb Alcohol Dependency

Post Your Comments:
(Date:11/27/2009)...lus low-emission vehicles may reduce future diseas...v. 27 (HealthDay News) -- Encouraging city dweller...offer much greater public health benefits than inc...hers have found. , The study compared the proje...and transport scenarios for London, England, and D...
(Date:11/27/2009)... Multi-purpose bilingual coloring books design...the business community to educate - inform parents...Safety issues to Dinosuars to ABC,S and a host of ...is, MO (PRWEB) November 27, 2009 -- Today’s ...to keep them busy any hour of the day, but one of ...
(Date:11/26/2009)....,Nov.27/PRNewswire/--ThediabetespopulationintheUn...ualmedicalspendingonthediseaseisprojectedtohit$336...blishedintheDecemberissueof DiabetesCare .TheNatio...fNovoNordisk,commissionedtheanalysisbyateamfromthe...thenumberofAmericanslivingwithdiabeteswillrisefrom...
(Date:11/26/2009)...ill when on an emotional rollercoaster, study find... -- Call it the fear factor meets the jubilant spo... -- especially those who root for the winning team...ely contested match and victory was in doubt, prod...w on that this Thanksgiving weekend as you,re glue...
(Date:11/26/2009)... Benton Communications announces a highly effe...r retailers struggling to make an economic recover... 2009 -- Flu fears is the type of challenge that c...om, according to Dr. David Benton, business growth...growth system – The Rfactor Intensive . &...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...crucial decision taken to delay action on Barr Pha...the FDA chief did not take two senior officials op...n sued by the non-profit Center for Reproductive R...he wanted to approve the drug. Still, in Galson’s ...
...bid to save its plummeting sales of chicken produc...vertisement campaign. //The campaign would ensure ...here is safe. This has been planned by McDonald... influence the customers. They have already pre...
...eservations are slowly thought to be extended to a...nal courses. The decision taken by the Maharashtra...rivate institutions. // They say that reservation...ntal Colleges of Maharashtra (AMUPMDCM) asked the ...
...dy that was published in Urology Journal BJUI Inte...ill wet the bed and almost half of 19-year-olds wh...// Researchers from the Chinese University o... researchers found that almost 3% of the children ...
...ny states of u.s., mothers who breastfed their bab...ncy. // As no act was made to prove that breastfee... safe for both mother and child. The U.S. ...alth Organization recommends that babies be breast...
...c, the popular drug for depression has been studie... in the brain. Researchers from the Cold Spring Ha...ound that the drug causes the production of immatu...ir study, analyzed proteins that were produced by ...
Other Medicine News:Health News:Breastfeeding Mothers Arrested For Public Indecency 2
(Date:11/25/2009)...AND,Colo.,Nov.25/PRNewswire-FirstCall/--HeskaCorpo...ddiagnosticandspecialtyproductstotheveterinaryindu...orporationforthesupplyofbloodgasproductsandaffilia... http://www.newscom.com/cgi-bin/prnh/20000622/HESK...innovatinginthefieldofadvancedpoint-of-carediagnos...
(Date:11/25/2009)...,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,In... report,thefirstinamulti-phasesyndicatedmarketres...ch,sStelara,fromproductlaunchthroughthefirstsixmon...itativeinformationfrom75uniqueDermatologistsandqua...strialanduseofStelara,obstaclestouse,typicalpatien...
(Date:11/25/2009)...NGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences...hromboticaptamerswithactivecontrolagents,announced...gatthePiperJaffray21stAnnualHealthCareConferenceat...ntationwillbegivenat1:10pm(EST)onTuesday,December1...emphasisontheleaddevelopmentprogram,theanticoagula...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 1D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 3Genetic Discovery May Improve Hepatitis C Treatment 54618 1Genetic Discovery May Improve Hepatitis C Treatment 54618 2
...ehensive overview of clinical trials, ...AGO, Aug. 13 Aon eSolutions, the client,technolog...ding provider of,global risk and insurance solutio... Trials module as part of RiskConsole, the market-...system (RMIS)., (Logo: http://www.newscom.com/cg...
... could provide therapeutic benefit in c...ARLSBAD, Calif., Aug. 13 Isis,Pharmaceuticals, In...ed a,Phase 1 study of ISIS 353512, an antisense dr...ein (CRP). CRP levels are frequently elevated,in p...ovascular disease,Crohn,s disease, rheumatoid arth...
Other Medicine Technology:Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3
Nerve Hook - Right
Single Skin Hook
Smith Expressor Hook
Osher "Y" Hook
Medicine Products: